Clovis Oncology
CLVS
#10443
Rank
S$15.06 M
Marketcap
S$0.10
Share price
0.00%
Change (1 day)
-95.14%
Change (1 year)

Clovis Oncology (CLVS) Fails to deliver data

Key failure to deliver metrics for Clovis Oncology:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Clovis Oncology (CLVS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Clovis Oncology (CLVS) - since 2013

Volume in USD (price x number of shares), data since 2013

Clovis Oncology (CLVS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2022S$0.10 B55.95%
2021S$64.22 M-74.65%
2020S$0.25 B-49.12%
2019S$0.49 B1053.83%
2018S$43.14 M68.49%
2017S$25.6 M-50.75%
2016S$51.99 M5.81%
2015S$49.14 M-8.09%
2014S$53.46 M1150.43%
2013S$4.27 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
S$67.61 MS$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$57.33 MS$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$0.13 BS$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$58.79 MS$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$1.45 MS$0.16 B๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
S$3.79 MS$16.56 M๐Ÿ‡บ๐Ÿ‡ธ USA